Delayed growth of glioma by Scutellaria flavonoids involve inhibition of Akt, GSK-3 and NF-κB signaling.
Delayed growth of glioma by Scutellaria flavonoids involve inhibition of Akt, GSK-3 and NF-κB signaling.
复制标题
DOI:
10.1007/s11060-010-0221-x
复制
发表时间:
2011-01
影响因子:
3.9
通讯作者:
Yadav AK
中科院分区:
文献类型:
--
作者:
Parajuli P;Joshee N;Chinni SR;Rimando AM;Mittal S;Sethi S;Yadav AK
Plants of the genus Scutellaria constitute one of the common components of Eastern as well as traditional American medicine against various human diseases, including cancer. In this study, we examined the in vivo anti-glioma activity of a leaf extract of Scutellaria ocmulgee (SocL) while also exploring their potential molecular mechanisms of action. Oral administration of SocL extract delayed the growth of F98 glioma in F344 rats, both in intracranial and subcutaneous tumor models. Immunohistochemistry revealed inhibition of Akt, GSK-3α/β and NF-κB phosphorylation in the subcutaneous tumors following treatment with Scutellaria. The SocL extract as well as the constituent flavonoid wogonin also showed dose- and time-dependent inhibition of Akt, GSK-3α/β and NF-κB in F98 cell cultures in vitro, as determined by western blot analysis. Pharmacologic inhibitors of PI3K and NF-κB also significantly inhibited the in vitro proliferation of F98 glioma cells, indicating the key role of these signaling molecules in the growth of malignant gliomas. Transfection of F98 cells with constitutively active mutant of AKT (AKT/CA), however, did not significantly reverse Scutellaria-mediated inhibition of proliferation, indicating that Scutellaria flavonoids either directly inhibited Akt kinase activity or acted downstream of Akt. In vitro Akt kinase assay demonstrated that the SocL extract or wogonin could indeed bind to Akt and inhibit its kinase activity. This study provides the first in vivo evidence and mechanistic support for anti-glioma activity of Scutellaria flavonoids and has implications in potential usage of Scutellaria flavonoids in adjuvant therapy for malignant tumors, including gliomas.
登录
查看更多内容
影响因子:
11.5
作者:
Miyashita, Katsuyoshi;Kawakami, Kazuyuki;Minamoto, Toshinari
通讯作者:
Minamoto, Toshinari
影响因子:
3.7
作者:
Korur S;Huber RM;Sivasankaran B;Petrich M;Morin P Jr;Hemmings BA;Merlo A;Lino MM
通讯作者:
Lino MM
影响因子:
6.4
作者:
Chung, Heekyoung;Jung, Youn -Mi;Kong, Gu
通讯作者:
Kong, Gu
影响因子:
1.6
作者:
Huang, Wen-Hsin;Lee, An-Rong;Yang, Ching-Huey
通讯作者:
Yang, Ching-Huey
影响因子:
4.8
作者:
Mathupala, SP;Parajuli, P;Sloan, AE
通讯作者:
Sloan, AE